An open-label phase II study to investigate the safety and efficacy of rituximab plus chlorambucil in previously untreated patients with CD20-positive B-cell chronic lymphocytic leukaemia (CLL) - Hillmen, P; Gribben, J G; Follows, G A (Blood (ASH Annual Meeting Abstracts), 2009)
et al.